CLEARWATER, FL– CoreRx, Inc., an industry-leading CDMO with formulation development, analytical services and GMP manufacturing sites in Clearwater, Florida and San Rafael, California announces significant investments to further support the requirements of its customers.
Noted capability additions include:
- Gerteis MINI-PACTOR and Gerteis MACRO-PACTOR
- IMA Practica 100 Encapsulator
- IMA Precisa 150 Capsule Weight Sorter
- Korsch XM12 High-Speed Single/Bi-Layer Tablet Press
- Xcelodose 600S Precision Powder Micro-Dosing System
Further, CoreRx has added the following product development and analytical technologies:
- Pion Rainbow 7-channel and 8-channel Dynamic Dissolution Monitor
- Logan Automated Transdermal Diffusion Cell Sampling System (Dry Heat)
CoreRx also announces that it has qualified its in-house Microbiology Laboratory, which brings greater efficiency and controls relative to the management and execution of required microbial limits testing.
“Our partners rely on us to bring their life-saving medicines to the clinic and market, quickly”, said Dan Bashour, Executive Director of Manufacturing Operations. “The continued investments in our people, our capabilities and our technologies allow CoreRx to provide integrated, expert solutions that meet their needs and exceed their expectations”.
ABOUT: CoreRx, Inc. is an industry leading Contract Development and Manufacturing Organization (CDMO), providing innovative drug formulation, development, GMP manufacturing and packaging solutions to global pharmaceutical and bio-pharmaceutical partners. From its state-of-the-art, multi-site campus in Clearwater, Florida and its early product development center in San Rafael, California, CoreRx delivers value-added solutions to its partners, from clinic to commercial scale, across a range of dosage forms.
For more information on CoreRx, please visit www.corerxpharma.com and follow CoreRx on LinkedIn www.linkedin.com/company/corerx-inc-
CONTACT:
William Sirico, Director of Marketing
PartneredSolutions@corerxpharma.com